Table 2.

Oncology data

Variable	Total
Adjuvant therapy omission	80 (25.2)
Pattern of failure
Postoperative complications	31 (38.8)
Deemed not necessarya	17 (21.2)
Baseline comorbidities (CACI ≥4)	16 (20)
Patient’s choice	8 (10)
Early recurrence	8 (10)
Chemotherapy regimen
Gemcitabine, monotherapy	99 (41.8)
mFOLFIRINOX	91 (38.4)
Gemcitabine-based polychemotherapy	37 (15.6)
Other regimens	10 (4.2)
Time discharge-chemotherapy start, weeks [median (IQR)]	8 (4.0)

Data are expressed as n (%) unless otherwise specified

CACI Charlson Age Comorbidity Index, IQR interquartile range

^aR0, or Stage I or Stage IIA